☆ 4.7 Article

Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes

DIABETES CARE (2011)

Get Full Text
Add to Collection

Journal

DIABETES CARE
Volume 34, Issue -, Pages S244-S250

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc11-s237

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. Daiichi Sankyo, Inc.
  2. Glaxo SmithKline
  3. Novo Nordisk
  4. sanofi-aventis
  5. Takeda Pharmaceuticals
  6. AstraZeneca
  7. Boehringer Ingelheim
  8. Bristol-Myers Squibb
  9. Eli Lilly
  10. Ethicon Endo-Surgery
  11. Generex Biotechnology
  12. F. Hoffmann-La Roche
  13. Janssen-Cilag
  14. Johnson Johnson
  15. Medtronic
  16. Pfizer

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.